EGF and neoplasm: Li et al, confirmed in cytological experiments that B3GNT3 promotes the glycosylation of PD-L1 in response to EGF stimulation and enhances the binding of PD-L1 to PD-1, thereby inhibiting the killing effect of T cells on tumor cells (25).